Wilcock DM - Search Results

1

Lithium treatment of APPSwDI/NOS2-/- mice leads to reduced hyperphosphorylated tau, increased amyloid deposition and altered inflammatory phenotype.

Sudduth TL, Wilson JG, Everhart A, Colton CA, Wilcock DM. Sudduth TL, et al. Among authors: wilcock dm. PLoS One. 2012;7(2):e31993. doi: 10.1371/journal.pone.0031993. Epub 2012 Feb 9. PLoS One. 2012. PMID: 22347510 Free PMC article.

2

Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2.

Wilcock DM, Lewis MR, Van Nostrand WE, Davis J, Previti ML, Gharkholonarehe N, Vitek MP, Colton CA. Wilcock DM, et al. J Neurosci. 2008 Feb 13;28(7):1537-45. doi: 10.1523/JNEUROSCI.5066-07.2008. J Neurosci. 2008. PMID: 18272675 Free PMC article.

3

Anti-amyloid-beta immunotherapy in Alzheimer's disease: relevance of transgenic mouse studies to clinical trials.

Wilcock DM, Colton CA. Wilcock DM, et al. J Alzheimers Dis. 2008 Dec;15(4):555-69. doi: 10.3233/jad-2008-15404. J Alzheimers Dis. 2008. PMID: 19096156 Free PMC article. Review.

4

The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP.

Colton CA, Wilcock DM, Wink DA, Davis J, Van Nostrand WE, Vitek MP. Colton CA, et al. Among authors: wilcock dm. J Alzheimers Dis. 2008 Dec;15(4):571-87. doi: 10.3233/jad-2008-15405. J Alzheimers Dis. 2008. PMID: 19096157 Free PMC article. Review.

5

Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice.

Wilcock DM, Colton CA. Wilcock DM, et al. CNS Neurol Disord Drug Targets. 2009 Mar;8(1):50-64. doi: 10.2174/187152709787601858. CNS Neurol Disord Drug Targets. 2009. PMID: 19275636 Free PMC article. Review.

6

Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease.

Wilcock DM, Vitek MP, Colton CA. Wilcock DM, et al. Neuroscience. 2009 Mar 31;159(3):1055-69. doi: 10.1016/j.neuroscience.2009.01.023. Epub 2009 Jan 19. Neuroscience. 2009. PMID: 19356689 Free PMC article.

7

Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer's disease.

Wilcock DM, Gharkholonarehe N, Van Nostrand WE, Davis J, Vitek MP, Colton CA. Wilcock DM, et al. J Neurosci. 2009 Jun 24;29(25):7957-65. doi: 10.1523/JNEUROSCI.1339-09.2009. J Neurosci. 2009. PMID: 19553436 Free PMC article.

8

Interaction of NG2(+) glial progenitors and microglia/macrophages from the injured spinal cord.

Wu J, Yoo S, Wilcock D, Lytle JM, Leung PY, Colton CA, Wrathall JR. Wu J, et al. Glia. 2010 Mar;58(4):410-22. doi: 10.1002/glia.20932. Glia. 2010. PMID: 19780197 Free PMC article.

9

Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence.

Wilcock DM, Morgan D, Gordon MN, Taylor TL, Ridnour LA, Wink DA, Colton CA. Wilcock DM, et al. J Neuroinflammation. 2011 Sep 9;8:115. doi: 10.1186/1742-2094-8-115. J Neuroinflammation. 2011. PMID: 21906275 Free PMC article.

10

Diverse inflammatory responses in transgenic mouse models of Alzheimer's disease and the effect of immunotherapy on these responses.

Wilcock DM, Zhao Q, Morgan D, Gordon MN, Everhart A, Wilson JG, Lee JE, Colton CA. Wilcock DM, et al. ASN Neuro. 2011 Nov 30;3(5):249-58. doi: 10.1042/AN20110018. ASN Neuro. 2011. PMID: 21995345 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters